Emerald Clinical Trials Wins ABEA Patient Recruitment Award
SINGAPORE, March 12, 2026 Emerald Clinical Trials, a leading global clinical research organization (CRO), has been honored with the...
Clinical Trials for New Therapy
LabConnect Expands Central Lab Network with Wuxi Facility
WUXI, China — March 11, 2026 LabConnect, a global provider of technology-driven central laboratory services for clinical trials, announced...
Celcuity Reports Phase 3 Gedatolisib Results in Breast Cancer
Minneapolis, USA – March 9, 2026 Celcuity Inc. has announced the publication of positive Phase 3 VIKTORIA-1 clinical trial...
Telix ProstACT Phase 3 Study Shows Positive Safety Results
Melbourne, Australia & Indianapolis, United States – March 10, 2026 Telix Pharmaceuticals has announced that Part 1 of the...
Dyne Launches Phase 3 HARMONIA Trial for DM1 Therapy
March 08, 2026 — Waltham, Massachusetts, USA Clinical-stage biotechnology innovator Dyne Therapeutics has announced the initiation of the Phase...
Insilico, TaiGen Advance CKD Anemia Drug Into Phase I Trial
March 06, 2026 — Cambridge, Massachusetts, USA A significant milestone has been reached in AI-driven pharmaceutical development as Insilico...
Genentech Reports Positive Phase II Results for Petrelintide
SOUTH SAN FRANCISCO, California – March 6, 2026 Genentech announced positive topline results from the Phase II ZUPREME-1 clinical...
Kallyope Advances Elismetrep Migraine Therapy in Phase 2b
NEW YORK, March 5, 2026 Kallyope announced that it will present Phase 2b clinical trial results for its investigational...
HLP004 Shows Strong Phase 2 Results in Anxiety Disorder
NEW YORK & TORONTO — March 5, 2026 Helus Pharma, a clinical-stage pharmaceutical company developing novel serotonergic agonists (NSAs)...
LYMPHIR Shows Strong Results Before CAR-T Lymphoma Therapy
CRANFORD, N.J., March 4, 2026 Citius Oncology announced encouraging preliminary topline results from a Phase 1 clinical study evaluating...